The Path to Power in Pharma

A Study of CEOs at the Top 50 Biopharmaceutical Companies

Skip to the end for key highlights and analysis.

Image for post
Image for post

The CEOs:

What follows are mini-bios of each CEO from the top 50 biopharma companies, ranked by 2017 prescription drug revenue. Note that J&J and Bayer fall lower than you may expect, as much of their revenue derives from CPG or agriculture.

Analysis:

Demographics:

Principal, RA Capital. Serve on boards of 6 biotech companies. Ex-Founder/CEO of Nivien Therapeutics. Writing is my own.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store